NexgenRx Announces Debenture Issuance

NEXGENRX INC. (TSX VENTURE:NXG) ("NexgenRx" or the "Corporation") is pleased to
announce that it has issued a convertible debenture in the aggregate principal
amount of $500,000 (the "Debenture"). The Debenture has been issued to an arm's
length party and is convertible (in whole or in part) into common shares in the
capital of the Corporation at a price of $0.30 on or before November 26, 2013.
The Debenture and any securities issuable upon conversion thereof is subject to
a four-month hold period in accordance with applicable securities laws, which
will expire on August 5, 2012. The Debenture is being issued as replacement for
the Corporation's previously issued convertible debenture in the principal
amount of $500,000, which was initially issued in April 2007 and matured and
came due in November 2011.


About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design,
management and administration of health benefit plans offered by employers and
other plan sponsors for the benefit of their employees and plan members. More
information on NexgenRx can be found at www.nexgenrx.com. 


Caution Regarding Forward-Looking Statements - This news release contains
certain forward-looking statements, including statements regarding the business
and anticipated financial performance of the Corporation. These statements are
subject to a number of risks and uncertainties. Actual results may differ
materially from results contemplated by the forward-looking statements. When
relying on forward-looking statements to make decisions, investors and others
should carefully consider the foregoing factors and other uncertainties and
should not place undue reliance on such forward-looking statements.

Nexgenrx (TSXV:NXG)
過去株価チャート
から 5 2024 まで 6 2024